NIFTY
-1.25  -0.01%
 10564.05
S&P BSE SENSEX
-11.71  -0.03%
 34415.58
Cadila Healthcare Ltd.
NSE : CADILAHC BSE : 532321 ISIN code : INE010B01027
on 20-Apr-2018
NSE
-2.5    -0.64%
Rs. 385.15
 
Days Low
Rs. 382.55
Days High
Rs. 388.55

Open Rs. 388
 
52 week Low
Rs. 361.45
52 week High
Rs.558
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.386.00
-0.65    -0.17%
on 20-Apr-2018 16:00
BSE
-0.65    -0.17%
Rs. 386.00
 
Days Low
Rs. 382.4
Days High
Rs. 388.5

Open Rs. 386.6
 
52 week Low
Rs. 362
52 week High
Rs.560
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.385.15
-2.5    -0.64%
 
 
Last Price (Rs.)  386.00 Value  8595448.00
Net Change (Rs.)  -0.65 Best Buy  0.00
Volume  22268 Best Sell  0.00
Prev.Close (Rs.)  386.65 Best Quantity  0
Open (Rs.)  388.00 Sell Quantity  0
High (Rs.)  388.55 52-Week High (Rs.)  558.00
Low (Rs.)  382.55 52-Week Low (Rs.)  361.45
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  395164.64
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Currents Investments0.00 1009.00 4583.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 509.35 1222095 81.32 0.00 0.69
Cipla 584.40 470512 172.31 48.22 0.34
Piramal Enterprises 2608.00 470154 879.19 57.93 0.80
Biocon 637.25 382350 110.72 24.55 0.16
Ranbaxy Labs. 859.90 366028 1.53 0.00 0.00
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2017Sep 2017Jun 2017
Net Sales15738.0017383.0010554.00
Operating Profit4672.007174.002504.00
PBDT4645.006934.002385.00
Net Profit3064.004498.00914.00
More> 
 
Company News
4/19/2018 12:00:00 AM
Announcement under Regulation 30 (LODR)-Press Release / Media Release
4/19/2018 12:00:00 AM
Zydus Cadila gets final nod from USFDA for Diclofenac Sodium Topical S...
4/19/2018 12:00:00 AM
Cadila Healthcare informs about press release
More>
 
Ratios
   Earnings Per Share (Rs)6.46 
   Book NAV/Share(Rs)64.63 
   PAT Margin (%)20.21 
   Asset Turnover(x)0.30 
   PER(x)68.57 
   Yield(%)0.72 
   EV/Core EBITDA(x)52.51 
   M Cap / Sales14.05 
   Net Sales Growth(%)-54.06 
   PAT Growth(%)-67.51 
   Total Debt/Equity(x)0.44 
   Current Ratio(x)0.71 
   Quick Ratio(x)0.40 
   Total Debt/Mcap(x)0.06 
More>